Pulmonary Medicine

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Hassan Bencheqroun, MD

Evaluating the need for therapy escalation can be challenging. So joining Dr. Charles Turck to help us understand how to escalate treatment for patients with chronic obstructive pulmonary disease is Dr. Hassan Bencheqroun, Assistant Professor of Medicine at the University of California Riverside School of Medicine.

This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Deborah Levine, MD, FCCP

To better understand whether or not corticosteroids should be incorporated in treatment for our patients with COPD, Dr. Charles Turck is joined by Dr. Deborah Jo Levine, a Professor of Medicine and Director of the Pulmonary Hypertension Center at the University of Texas Health.

This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.

Host: Mario R. Nacinovich, Jr., MSc

Guest: Randy Young, MD

Amid the surge of the Delta variant, critical care physician Dr. Randy Young is traveling to ICUs across the country to help treat patients. Tune in to hear Dr. Young share how this surge is impacting both patients infected with the variant and the healthcare professionals caring for them.

Host: Jacob Sands, MD

Guest: Shirish Gadgeel, MD

Immunotherapy using checkpoint inhibitors has become a standard of practice in advanced non-small cell lung cancer. But can combination therapy further improve patient outcomes? Dr. Jacob Sands is joined by Dr. Shirish Gadgeel, Chief of the Division of Hematology and Oncology at Henry Ford Cancer Institute, who recently spoke about this topic at the American Society of Clinical Oncology’s annual meeting.

Host: Jacob Sands, MD

Guest: Derek Raghavan, MD, PhD, FACP, FRACP

CT scans have the potential to dramatically improve lung cancer outcomes, but are underserved communities receiving access to these types of screenings? Dr. Jacob Sands joins Dr. Derek Raghavan, President of Atrium Health Levine Cancer Institute in Charlotte, North Carolina, to discuss his research presented at the American Society of Clinical Oncology Annual Meeting.

Host: Matthew S. Keller MD

Guest: Maria L. Wei MD, PhD

Wildfires are most often associated with respiratory and cardiovascular health threats, but could they also affect the skin? That’s the exact question dermatologist and melanoma specialist Dr. Maria Wei sought to answer with her recent study and the one that she addresses with Dr. Matthew Keller.

Host: Jacob Sands, MD

Guest: Millie Das, MD

What are some of the latest advancements in small cell lung cancer? Dr. Jacob Sands discusses small-cell lung cancer treatment developments with Dr. Millie Das, a Clinical Associate Professor of Medical Oncology at Stanford University and Chief of Oncology at the Veteran’s Affairs Palo Alto Healthcare System.

Host: Matthew P. Bars, MS, CTTS, NCTTP

Guest: Michael C. Fiore, MD, MPH, MBA

Guest: Laura E. Crotty Alexander, MD

Dr. Matt Bars is joined by his two colleagues: Dr. Laura Crotty Alexander, Associate Professor of Pulmonary Critical Care Medicine at the University of California San Diego, and Dr. Michael Fiore, Professor of Medicine at the University of Wisconsin and Director of the University of Wisconsin Center for Tobacco Research Intervention. Together, they review tobacco dependence, the CHEST Tobacco Dependence Treatment Toolkit, and resources to help patients.

Supported in part by an independent medical educational grant from Pfizer.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Ana C Zamora Martinez, MD

The COVID-19 pandemic led many clinicians to make life-altering decisions. Dr. Ana Zamora, a pulmonary disease and critical care specialist, discusses her work with Locum Tenens and why she decided it was time for a change.

Host: Jacob Sands, MD

Guest: Mark Awad, MD, PhD

Immunotherapy has led to impressive results, but when is it needed? Dr. Jacob Sands discusses the role of immunotherapy in managing lung cancer with Dr. Mark Awad, a thoracic medical oncologist, Clinical Director of the Lowe Center for Thoracic Oncology at the Dana-Farber Cancer Institute, and Assistant Professor of Medicine at Harvard Medical School.­